BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 18, 2015
View Archived Issues
[11C]PF-367: a promising PET tracer for neuroimaging of GSK-3
Read More
Phase I/IIa results disclosed for therapeutic p16 HPV vaccine
Read More
Sareum secures funding to investigate TYK2 inhibitors for T-ALL
Read More
INV-17, a RORgT inverse agonist, demonstrates complete survival in MRL/lpr mice
Read More
GenSpera receives grant from FDA OOPD to develop mipsagargin for glioblastoma
Read More
Synergy Pharmaceuticals reports phase III results for plecanatide in CIC
Read More
Merck & Co. discloses Nav1.7 sodium channel blockers
Read More
Chong Kung Dang presents GPR119 agonists
Read More
Kyorin introduces FPR2 agonists
Read More
Nektar Therapeutics discloses opioid agonists
Read More
Incyte develops BRD4 inhibitors
Read More
Actavis adopts Allergan name
Read More
Clinical benefit seen with autologous T cells specific for HER2 and CMV in glioblastoma multiforme
Read More
HemoShear changes name to reflect new focus on discovery of novel therapeutics
Read More
Biosimilar etanercept SB-4 found equivalent in phase III study in RA
Read More
Velicept to merge with AltheRx to advance development of solabegron
Read More
Merck KGaA's acquisition of Sigma-Aldrich cleared by EC and Chinese authorities
Read More
Lilly forges new oncology collaborations
Read More
FDA approves Ventana's companion diagnostic test for Xalkori
Read More
University of Queensland to lead project on MERS
Read More
Genentech and Almac Discovery to develop ubiquitin-specific protease inhibitors
Read More
Radius Health reports results from phase III trials of abaloparatide in osteoporosis
Read More
First clinical data of namilumab in patients with active RA
Read More
FORMA Therapeutics achieves milestones under agreements with Celgene and Boehringer Ingelheim
Read More
Improvement in growth velocity observed in phase II study of BMN-111 for achondroplasia
Read More